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Purpose or Objective: Most institutes use the ITV approach to account for breathing motion into treatment planning, generally yielding too large treatment volumes. Recent publications showed that use of a mid-ventilation CT (midV-CT, representing the mean breathing phase) and treating remaining breathing motions as a random error, led to high tumor control and overall survival for hypo-fractionated treatments. However, the midV-CT is not available commercially yet. In this work we perform a marker-based validation of our open-source software to generate a midV-CT for upper abdomen cancer patients.
Material and Methods:
Planning data from 12 upper abdominal cancer patients (8 liver-and 4 pancreatic patients) were used for this study. These patients were treated with the ITV approach using hypo-fractionated schemes (ranging from 5x7.5 Gy to 1x24 Gy). Each patient had a gold marker implanted close to the CTV center of mass (COM). 4DCT data consisted of 10 amplitude-based breathing phases (CT BrillianceTM, Phillips). In our planning system (EclipseTM,Varian), the position of the marker was measured by hand for each breathing phase and patient. In the opensource medical imaging 3DSlicer, B-spline deformable registration was used to register the plan CT and the different phases of the 4DCT. The resulting transformation matrices were then used by our 3DSlicer modules to automatically generate the midV-CT and the COM motions of any planning volume or marker. Subsequently, the marker position in the midV-CT was compared to the average marker position in Eclipse. Furthermore, the Eclipse marker motion curves and amplitudes were compared with the marker and CTV motions from 3DSlicer. Additionally, treatments plans were generated for one patient using the midV-CT and compared with our ITV-based clinical plan.
Results:
The mean CTV volume was 24.7±22.0 cc (1SD) and the mean marker to CTV COM distance was 12.7±6.2mm (1SD). The midV CTs are generated by 3DSlicer within 30 minutes using a PC. Motion validation results are shown in Table 1 . Differences in the mean COM of the marker in Eclipse and in midV-CT are within 1 mm, indicating an accurate midV-CT generation by our software. Average amplitude differences are within 1 mm but Eclipse motions tend to be slightly larger, possibly due to the uncertainty of manually finding the marker in the 4D phases. Correspondingly, RMS differences between motion curves of Eclipse and 3DSlicer were therefore 0.2-0.6 mm, whereas the RMS differences between marker and CTV motion in 3DSlicer only 0.1-0.2 mm (Fig 1a) . The latter suggests that wellplaced markers can estimate CTV motions. Fig 1b shows differences in dose volume histograms between the ITV and the midV-CT approach.
Material and Methods: FDG-PET/CT imaging was performed in 70 lung cancer patients. Amplitude-based optimal respiratory gating (ORG) was performed on bed positions covering the thorax. The duty cycle (percentage of the total PET data) used for image reconstruction of ORG images was 35%. Non-gated images were reconstructed using 126 seconds of PET data, yielding similar noise characteristics as ORG. Lesion segmentation was performed using the fuzzy locally adaptive Bayesian (FLAB) algorithm. Four heterogeneity parameters (entropy, dissimilarity, zone percentage (ZP), and high energy emphasis (HIE)), which have previously shown to be robust and associated with survival in lung cancer, were calculated in non-gated and ORG images.
Results: Respiratory gating did not result in statistically significant differences in the heterogeneity parameters. Subgroup analysis revealed a significant effect of ORG on the heterogeneity parameters of lesions in the lower lobes. The mean increase for entropy, dissimilarity, ZP and HIE, considering lesions in the lower lobes was 1.3±1.5% (p=0.02), 11.6±11.8% (p= 0.006) 2.3±2.2% (p= 0.002), and 16.8%±17.2% (p=0.006) respectively. For the centrally located lesions, the mean increase for entropy, dissimilarity, ZP and HIE was 0.58±3.7% (p= 0.6), 5.0±19.0% (p=0.4) 0.59±4.0% (p= 0.9), and 4.4±27.8% (p= 0.4), respectively. Lesions in the upper lobes showed a mean increase of -0.35±1.8 (p= 0.3), -1.0±7.7% (p=0.3), -0.4±2.7% (p= 0.5), -1.7±13.2% (p= 0.4), for entropy dissimilarity, ZP and HIE, respectively. There was no significant correlation between lesion volume and the change in parameters between non-gated and ORG images.
Conclusion:
Results from this study indicate that ORG significantly impacts characterisation of intra-tumour heterogeneity, particularly for lesions in the lower lung lobes. This suggests that adequate management of respiratory motion artefacts is important for improving characterisation of intra-tumour heterogeneity in PET. Material and Methods: Forty-two RCPs were treated within a prospective observational study. CH consisted of oxaliplatin (on days: -14, 0, 14) and 5-fluorouroacil (from day -14 to end) being day 0 the start of RT. All patients were treated with Helical Tomotherapy (18x2.3Gy) with an adaptive concomitant boost technique delivering 3Gy/fr on the residual gross tumor volume (GTV) in the last 6 fractions (fr), based on MRI imaging taken at fr 9. GTVs were contoured by a single radiologist on axial T2 MRI images acquired for initial planning (V_PRE), at fr 9 for the adaptive planning (V_MID) and before surgery, after a median time of 8.9 weeks after the end of RCH (V_POST). Based on a Poisson-like tumor regression model and neglecting repopulation and interpatient variability of the removal kinetics of killed cells, the parameter (1-ΔV(D))^V_PRE was taken as a surrogate of tumor control probability (TCP), where ΔV(D)=V_MID/V_PRE or V_POST/V_PRE, considering D at fr 9 (TCP_MID) or at the end of RCH (TCP_POST). The discriminative power of TCP_MID/POST in predicting the pathological complete remission (pCR, n= 14) was assessed by the AUC of the corresponding ROC curves. Then, two-variables logistic (LOG) models including V_PRE and ΔV(D) as covariates were also considered and the ROC curves of the four models (TCP_MID,TCP_POST,LOG_MID, LOG_POST) were compared. In addition, an estimate of the residual cells at surgery (V_S) was robustly taken as the product of the pathologically assessed fraction of viable cells and V_POST. Spearman correlation rank test was used to evaluate the correlation between the models and V_S.
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Results: All models showed a high discriminative power in predicting pCR (p-value<0.0001). AUCs for TCP_ MID was 0.87 (specificity: 71.4%, sensitivity: 96.4%, best cut-off: 5.85), higher than TCP_POST (0.82), although the difference did not reach significance (p= 0.18). TCP_MID/TCP_POST were also highly correlated with V_S (R= 0.77 and 0.74,p<0.0001). Similar performances were found for LOG_MID/LOG_POST with AUC = 0.90/0.87 and R = 0.79/0.77. No significant differences were found when comparing TCP models against the corresponding LOG models.
Conclusion:
A radiobiologically consistent model including early regression (TCP_MID) measured on T2-MRI images well predicts pCR and is strongly correlated with the estimated residual cells number after adaptive RCH; similar performances were obtained with a logistic model including V_PRE and V_MID/V_PRE. The corresponding models using V_POST showed a slightly, statistically not significant, worse
